LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 50.33 | 17.25 | 5304 | 4651 | 1.1404 | 1.0328 | MN20160310_N02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 50.33 | 17.25 | 3885 | 4651 | 0.8353 | 0.9559 | MN20160310_N02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 50.33 | 17.25 | 5344 | 4651 | 1.1490 | 1.0347 | MN20160310_N02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 52.30 | 17.25 | 638 | 4798 | 0.1330 | 0.5599 | MN20160310_N02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 52.30 | 17.25 | 5704 | 4798 | 1.1887 | 1.0430 | MN20160310_N02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 52.30 | 17.25 | 3645 | 4798 | 0.7596 | 0.9334 | MN20160310_N02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 52.30 | 17.25 | 5724 | 4798 | 1.1929 | 1.0439 | MN20160310_N02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 54.27 | 17.25 | 647 | 4884 | 0.1325 | 0.5605 | MN20160310_N02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 54.27 | 17.25 | 6126 | 4884 | 1.2543 | 1.0564 | MN20160310_N02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 54.27 | 17.25 | 3125 | 4884 | 0.6398 | 0.8933 | MN20160310_N02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 54.27 | 17.25 | 6293 | 4884 | 1.2885 | 1.0632 | MN20160310_N02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 56.24 | 17.25 | 452 | 4929 | 0.0917 | 0.4923 | MN20160310_N02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 56.24 | 17.25 | 6614 | 4929 | 1.3418 | 1.0734 | MN20160310_N02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 56.24 | 17.25 | 3080 | 4929 | 0.6249 | 0.8880 | MN20160310_N02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 56.24 | 17.25 | 6924 | 4929 | 1.4047 | 1.0851 | MN20160310_N02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 58.21 | 17.25 | 369 | 4942 | 0.0747 | 0.4554 | MN20160310_N02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 58.21 | 17.25 | 7131 | 4942 | 1.4428 | 1.0919 | MN20160310_N02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 58.21 | 17.25 | 2807 | 4942 | 0.5679 | 0.8661 | MN20160310_N02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 58.21 | 17.25 | 7443 | 4942 | 1.5059 | 1.1029 | MN20160310_N02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 60.18 | 17.25 | 301 | 5031 | 0.0598 | 0.4179 | MN20160310_N02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 60.18 | 17.25 | 7648 | 5031 | 1.5200 | 1.1049 | MN20160310_N02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 60.18 | 17.25 | 2222 | 5031 | 0.4416 | 0.8100 | MN20160310_N02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 60.18 | 17.25 | 7920 | 5031 | 1.5741 | 1.1139 | MN20160310_N02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 63.15 | 17.25 | 124 | 5061 | 0.0245 | 0.2721 | MN20160310_N02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 63.15 | 17.25 | 8163 | 5061 | 1.6129 | 1.1201 | MN20160310_N02 | G05 |